Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.41 |
| ▸ | PPARG | P37231 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | LIPC | P11150 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2239578 | 0.91 | REN (0.41) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL2242992 | 0.85 | REN (0.43) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL2820607 | 0.85 | REN (0.47) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL2243744 | 0.84 | CYP3A4 (0.44) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL2820593 | 0.82 | REN (0.41) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL12354040 | 0.82 | POLB (0.36) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL12352905 | 0.82 | POLB (0.36) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL2241986 | 0.81 | REN (0.41) | RENPPARGCYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL2239580 | 0.80 | REN (0.41) | RENCYP2C19ALDH1A1MEN1KMT2A | |
| SCHEMBL2245159 | 0.79 | REN (0.34) | RENPPARGCYP3A4CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389511-B2 | Bicyclic heterocyclic derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| EP-2243779-A1 | BICYCLIC HETEROCYCLIC DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2010-10-27 | — | — | EP | disclosed |